Upstream Bio (UPB) Treasury Shares (2023 - 2026)

Upstream Bio (UPB) posted quarterly Treasury Shares of $341456.0 for Q1 2026, down 98.93% quarter-over-quarter from $31.8 million in Q3 2024.

Upstream Bio (UPB) Treasury Shares (2023 - 2026) Analysis & Trends

Upstream Bio's Treasury Shares history runs 3 years deep, the most recent figure standing at $341456.0 for Q1 2026.

In Q1 2026, Treasury Shares changed N/A year-over-year to $341456.0; the TTM figure through Mar 2026 stood at $341456.0 (changed N/A YoY), while the FY2023 annual figure was $22.9 million, changed N/A from the prior year.
Treasury Shares for Q1 2026 stood at $341456.0, down from $31.8 million in the prior quarter.
The five-year high for Treasury Shares was $31.8 million in Q2 2024, with the low at $341456.0 in Q1 2026.
The 3-year median for Treasury Shares is $22.9 million (2023), against an average of $22.1 million.
Peak annual rise in Treasury Shares reached 38.46% in 2024, while the deepest fall reached 38.46% in 2024.
Upstream Bio's Treasury Shares stood at $22.9 million in 2023, then jumped by 38.46% to $31.8 million in 2024, then plunged by 98.93% to $341456.0 in 2026.
Business Quant data shows UPB's Treasury Shares at $341456.0 in Q1 2026, $31.8 million in Q3 2024, and $31.8 million in Q2 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	Upstream Bio	387.23 Mn	387.23 Mn	-3.29 Mn	327,520.00

Download Data